Apollo Therapeutics is a startup that operates in the pharmaceutical industry, specifically in the area of drug development. The company's primary business model revolves around creating a portfolio of drugs at scale in a capital-efficient manner. This means that they aim to develop multiple drugs simultaneously while keeping costs low, which is a unique approach in the industry.

Apollo Therapeutics serves a broad range of clients, including healthcare providers, pharmaceutical companies, and potentially patients who require the drugs they develop. Their market is global, given the universal need for effective and affordable medications.

The company makes money by developing drugs and then selling them to healthcare providers or pharmaceutical companies. They may also generate revenue through partnerships or licensing agreements with other companies that wish to produce and sell the drugs they develop.

In terms of financial analysis, Apollo Therapeutics' capital-efficient model could potentially offer high returns. By developing multiple drugs at once, they increase the chances of producing a successful product. Furthermore, by keeping costs low, any revenue generated can result in significant profit.

Keywords: Drug Development, Pharmaceutical Industry, Capital-Efficient, Portfolio, Healthcare Providers, Global Market, Licensing Agreements, Partnerships, High Returns, Cost-Effective.